Medical Xpress
Retraining the immune system to treat type 1 diabetes
Researchers are exploring a new frontier in type 1 diabetes treatment: transplanting healthy islet cells into the pancreas to restore insulin production. The catch has long been that patients must take immunosuppressants to prevent rejection — a significant burden with its own risks. Scientists are now working to retrain the immune system itself to accept the transplant, potentially offering a more durable, medication-free solution.
Read article →
Stat News
STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
Pancreatic cancer patient Amy Johnston is fighting to access a promising experimental treatment after exhausting standard options including chemotherapy and surgery. Her struggle highlights a broader crisis in oncology: cutting-edge drugs often remain frustratingly out of reach for the patients who need them most. For a disease with a five-year survival rate below 15%, the gap between medical innovation and patient access carries life-or-death consequences.
Read article →Medical Xpress
Semaglutide linked to better quality of life in diabetes and kidney disease, trial shows
Semaglutide continues to build its case as a transformative treatment, with FLOW trial data showing the GLP-1 drug delivers measurable quality-of-life gains for patients managing both type 2 diabetes and chronic kidney disease. Presented at the ERA Congress, the findings translate the benefit into a tangible metric: roughly eight additional days per year lived in full health. For a patient population already navigating a heavy disease burden, that margin is clinically meaningful.
Read article →Medical Xpress
Nearly seven million kids live in a home where guns aren't securely stored
Nearly 6.7 million American children live in homes with at least one unlocked and loaded firearm, according to a new Northeastern University study published in JAMA Network Open. The findings carry serious weight given that guns are already the leading cause of death for children in the United States. Researchers say the data underscores an urgent need for stricter safe storage practices among gun-owning households.
Read article →Medical Xpress
New post-liver transplant protocol results in 0% heavy alcohol relapse rate
Mayo Clinic researchers have achieved a landmark result in post-transplant care, reporting zero cases of heavy alcohol relapse among liver transplant patients who followed a new proactive treatment protocol for alcohol use disorder. The finding stands in stark contrast to the historical relapse rate of roughly 25%, suggesting the protocol represents a significant leap forward in long-term outcomes. Published in the journal *Liver Transplantation*, the study makes a compelling case for rethinking how transplant centers manage addiction recovery after surgery.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →